A Las Vegas jury was excused from an Actos trial after plaintiffs and defendants reached a resolution agreement. In addition to the two plaintiffs involved in this case, thousands of other plaintiffs across the country are now participating in an Actos settlement reached in April regarding... Read More

With a sufficient number of participants now enrolled in the Actos Resolution Program, manufacturer Takeda has announced the company will move forward with the resolution process. The resolution program, which was proposed by Takeda to settle a growing number of lawsuits against the company, has... Read More

A Las Vegas jury has begun hearing arguments regarding potential safety problems linked to Actos, a medication designed and manufactured by Takeda Pharmaceuticals. The Actos trial began on August 27th, 2015 before Judge Jerry Wiese in the Las Vegas District Court. During this high stakes... Read More

A recent analysis published in JAMA Internal Medicine shows that 10 percent of cases where a drug causes severe harm to patients are not reported to the FDA within the specified 15-day time period. This lag time in reporting serious adverse events endangers lives needlessly,... Read More

On the heals of Takeda Pharmaceuticals reaching a multi-billion dollar settlement agreement with thousands of Actos bladder cancer plaintiffs, a new study raises concerns about additional side effects of the drug, including increased risk of pancreatic and prostate cancers. The study, published in The Journal... Read More

A number of plaintiffs from Tucson, AZ have filed a joint Actos lawsuit against Takeda Pharmaceuticals. Their lawsuit will join thousands currently pending under multidistrict litigation in the U.S. District Court for the Western District of Louisiana. Garry and Ruth Buchman are among the group... Read More

Takeda Pharmaceuticals has agreed to a $2.4 billion Actos settlement that would largely resolve thousands of claims regarding the drug’s risk of bladder cancer. The company said that the settlement would go into effect if at least 95% of current plaintiffs accept it; in this... Read More

Periodically, the U.S. Food and Drug Administration (FDA) requests reviews of medications to determine if they present a potential safety risk. Diabetes medications in particular have proven problematic because of potential complications. These include a possible risk of bladder cancer for those taking Actos, and... Read More